According to the information, this step has been taken after the Phase III clinical trial of Bharat Biotech. This clinical trial has shown the efficacy and safety of the vaccine in about 25,800 adults.
Approval has been sought from the Government of Canada for the vaccine.
For the COVID-19 vaccine, Occugen Inc., partner of Bharat Biotech in the US and Canada, has applied to Health Canada for approval of the vaccine. The American company gave this information in a regulatory notice. Health Canada is a department of the Government of Canada responsible for national health policy. According to the information, this step has been taken after the Phase III clinical trial of Bharat Biotech. This clinical trial has shown the efficacy and safety of the vaccine in about 25,800 adults.
The application has been submitted to Health Canada for rolling review. With which this department of the Government of Canada can start a review about the vaccine immediately. Occugen has applied through its sister company Vaxigen Ltd.
Health Canada will make a decision based on a review of the evidence presented to support the safety, efficacy and quality of the vaccine.
Bharat Biotech expects Covaxin to join EUL soon
Let us tell you that Bharat Biotech is expected to get the Emergency Use List (EUL) from the global body soon. The company says that they have submitted all the documents required for the Emergency Use List (EUL) of Covaxin to the WHO.
Bharat Biotech provided all necessary documents for emergency use list
Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech said that all the documents required for the Emergency Use List (EUL) of Covaxin have been submitted to WHO by July 9. The review process has now started with the expectation that we will receive the EUL from WHO at the earliest.
Indeed, a WHO pre-qualification or EUL is required for a vaccine company to supply vaccines to global facilities such as Covax or international procurement. The WHO has approved vaccines from Pfizer-BioNtech, AstraZeneca-SK Bio/SII, Johnson & Johnson Jensen, Moderna and Sinopharm for emergency use.
Covaccine is India’s indigenous vaccine
Covaccine is India’s indigenous corona vaccine. It is being manufactured by Bharat Biotech. In the ongoing vaccination campaign in India, this vaccine is playing a leading role in the fight against Corona. Earlier, WHO Chief Scientist Soumya Viswanathan had also said that the World Health Organization (WHO) will take a decision on including Bharat Biotech’s anti-Covid-19 vaccine Covaxin in the Emergency Use List (EUL) in four to six weeks. could.
read this also:
Kanwar Yatra 2021: Hearing in Supreme Court on Kanwar Yatra, Center said – permission cannot be given, UP government should transport Gangajal from tankers to temples
‘If the corona crisis is not controlled, the situation will be frightening’, PM Modi said after meeting with six states including Maharashtra-Kerala